International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Start Date
10/13/2022
Completion Date
5/31/2027
Summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
Eligibility Criteria
Age Range: 12 years to 65 years
Conditions
Locations
SARRC
Phoenix, Arizona 85006
United States
California Neuroscience Research
Sherman Oaks, California 91403
United States
BioPhase Research
Miami, Florida 33137
United States
The Angel Medical Research
Miami Lakes, Florida 33016
United States
Rush University Medical Center
Chicago, Illinois 60612
United States
University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders
Columbia, Missouri 65211
United States
Golden Hearts Diagnostic
Alamogordo, New Mexico 88210
United States
Red Oak Psychiatry Associates
Houston, Texas 77090
United States
Alpine Research Organization
Clinton, Utah 84015
United States
Children's Health Queensland Hospital and Health Service
South Brisbane, Queensland 4101
Australia
Mater Misericordiae Limited
South Brisbane, Queensland 4101
Australia
Flinders Medical Centre
Bedford Park, South Australia 5042
Australia
Locuspsych
Melbourne, Victoria 3004
Australia
Murdoch Children's Research Institute
Parkville, Victoria 3052
Australia
Hospital General Universitario Dr Balmis
Alicante, 30010
Spain
Hospital Clinic of Barcelona
Barcelona, 8036
Spain
Hospital Infantil Universitario Nino Jesus (HIUNJS)
Madrid, 28009
Spain
Hospital universitario Infanta Leonor
Madrid, 28031
Spain
Hospital Universitario Puerta De Hierro Majadahonda
Majadahonda, 28222
Spain
Policlina Gipuzkoa
San Sebastián, 20014
Spain
Hospital Álvaro Cunqueiro
Vigo, 36213
Spain